Stratus® Medical Adds Fifth US Patent and Two Canadian Patents to its 29-Patent Global IP Portfolio for the NIMBUS® Electrosurgical RF Multitined Expandable Electrode
MAGNOLIA, Texas, Nov. 8, 2023 /PRNewswire/ — Stratus® Medical, a company focused on improving clinical outcomes for chronic pain patients by advancing radiofrequency (RF) technology for the treatment of pain, today announced the issuance of its fifth U.S. patent (U.S. Patent No. 11,806,070 ) and the first two Canadian patents (Canadian patent). Nos. 2,778,997 and 2,799,505) for the NIMBUS® Electrosurgical RF multitine expandable electrode (“NIMBUS”).
These important patents further protect NIMBUS’ valuable intellectual property for its highly differentiated pain ablation technology. The company now holds 29 issued patents and 11 pending patent applications for its technology and will continue to file additional applications. NIMBUS is rapidly gaining market share in the US and other key markets around the world, where Stratus Medical distributes through both direct sales representatives and distributor partners.
Bret Boudousquie, CEO of Stratus Medical, said: “We continue to invest in our patents, trademark registrations and trade secrets for our valuable RF ablation technologies. We are committed to making NIMBUS the preferred ablation technology for the treatment of pain and are fortunate to work with many of the leading physicians and hospitals in the United States, United Kingdom, Australia, Brazil, Spain and other countries using NIMBUS to improve the quality of life. for patients.”
Amitabh Gulati, MD, a board-certified, interventional pain medicine physician based in New York City and president of the World Academy of Pain Medicine United (WAPMU), noted: “We have used NIMBUS RF ablation technology to treat spine and joint-related problems. to deal with. pain in our practice for the past four years and are satisfied with our clinical results. NIMBUS deployable teeth are unique and provide technical simplicity during placement, reducing overall procedure time. In addition, we are conducting ongoing research that will validate the improved lesion size and shape of the NIMBUS ablation zone compared to standard radiofrequency needling. We believe these qualities support NIMBUS as the preferred RF ablation technology for clinical and educational use.”
About Stratus® Medical – Stratus Medical’s mission is to improve clinical outcomes for patients with chronic pain by advancing RF technology. The NIMBUS® Electrosurgical RF Multitined Expandable Electrode (“NIMBUS”), in combination with a radio frequency (RF) generator and thermocouple probe, is intended for use in RF heat lesion procedures for pain relief. NIMBUS is FDA approved and CE marked. NIMBUS is easy to implement into the existing workflow, has demonstrated reduced procedure time and delivers significant savings for many of our customers. Stratus Medical continues to invest in the development of future technologies that align with our mission. Our headquarters are located in Magnolia, Texas.
Media contact
Cody Jorgensen
Director, Marketing
Stratus Medical
346-703-0642
cody@stratusmedical.com
SOURCE Stratus Medical
